acetylcysteine has been researched along with Auricular Fibrillation in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 15 (57.69) | 24.3611 |
| 2020's | 6 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Amar, D; Chung, MK; Desiderio, D; Fischer, GW; Isbell, JM; Jones, DR; Meyers, BF; Milne, GL; Molena, D; Park, BJ; Pedoto, A; Roistacher, N; Rusch, VW; Tan, KS; Zhang, H | 1 |
| Ghafari, R; Habibi, V; Heydari, S; Iranian, M; Jalalian, R; Maleki, M | 1 |
| Kawashima, S; Kinoshita, H | 1 |
| Amar, D; Chung, MK; Jones, DR | 1 |
| Huang, W; Li, B; Wen, J | 1 |
| Chukhliaev, PV; Garbuzov, AA; Khavkina, DA; Ploskireva, AA; Ruzhentsova, TA | 1 |
| Alipour, A; Azizi, S; Emami Zeydi, A; Habibi, MR; Habibi, V; Hasanzadeh Kiabi, F; Sohrabi, FB; Soleimani, A | 1 |
| Akbarzadeh, F; Ghasemi, K; Kazemi, B; Safaei, N; Shadvar, K; Yaghoubi, A | 1 |
| Dieleman, JM; Jacob, KA; Kluin, J; Nathoe, HM; van Dijk, D; van Osch, D | 1 |
| Akcay, S; Ceyhan, BM; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Sutcu, R; Uysal, BA; Varol, E; Yucel, H | 1 |
| Ali-Hassan-Sayegh, S; Dehghan, HR; Kayvanpour, E; Liakopoulos, OJ; Mirhosseini, SJ; Popov, AF; Rezaeisadrabadi, M; Sedaghat-Hamedani, F | 1 |
| Fan, GH; Liu, XH; Xu, CY | 1 |
| Chin, CT; Lim, SL; Ng, CY; Tan, CS; Tan, PH; Woo, KT; Zhu, L | 1 |
| Ali- Hasan- Al- Saegh, S; Dehghan, AM; Ghanei, A; Ghodratipour, Z; Haddad, F; Karimi-Bondarabadi, AA; Lotfaliani, M; Mahdavi, P; Mirhosseini, SJ; Popov, AF; Rahimizadeh, E; Sabashnikov, A; Sarrafan-Chaharsoughi, Z; Shahidzadeh, A; Tahernejad, M; Weymann, A; Zeriouh, M | 1 |
| Barrios, V; Calderon, A; Escobar, C; Lahera, V | 1 |
| Dogan, A; Erdogan, D; Ibrisim, E; Ozaydin, M; Peker, O; Turker, Y; Varol, E | 1 |
| Cardounel, AJ; Carnes, CA; Gyorke, S; Hamlin, RL; Khan, M; Nakayama, T; Nishijima, Y; Sridhar, A; Terentyev, D; Terentyeva, R | 1 |
| Albini, A; Cammarota, R; De Flora, S; Donatelli, F; Noonan, DM; Pennesi, G | 1 |
| McCarty, MF | 1 |
| Davis, EM; Hilleman, DE; Packard, KA | 1 |
| Aung, LH; Gu, WJ; Wang, PF; Wu, ZJ; Yin, RX | 1 |
| Akcay, S; Ceyhan, BM; Dogan, A; Erdogan, D; Etli, M; Icli, A; Ozaydin, M; Peker, O; Sutcu, R; Varol, E; Yavuz, T; Yucel, H | 1 |
| Akcay, S; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Varol, E; Yucel, H | 1 |
| Darbar, D; Gainer, JV; Motsinger, AA; Ritchie, MD; Roden, DM | 1 |
| Dogan, A; Erdogan, D; Ibrisim, E; Kapan, S; Ozaydin, M; Ozguner, F; Peker, O; Turker, Y; Varol, E | 1 |
| Erdogan, O | 1 |
9 review(s) available for acetylcysteine and Auricular Fibrillation
| Article | Year |
|---|---|
Inflammation in new-onset atrial fibrillation after cardiac surgery: a systematic review.
Topics: Acetylcysteine; Anti-Inflammatory Agents; Antioxidants; Atrial Fibrillation; Biomarkers; Cardiac Surgical Procedures; Colchicine; Epidemiologic Methods; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Postoperative Complications; Steroids; Vitamins | 2014 |
Antioxidant supplementations for prevention of atrial fibrillation after cardiac surgery: an updated comprehensive systematic review and meta-analysis of 23 randomized controlled trials.
Topics: Acetylcysteine; Anti-Arrhythmia Agents; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Cardiac Surgical Procedures; Dietary Supplements; Fatty Acids, Unsaturated; Humans; Length of Stay; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: a meta-analysis of published randomized controlled trials.
Topics: Acetylcysteine; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Chi-Square Distribution; Humans; Incidence; Intensive Care Units; Length of Stay; Odds Ratio; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Warfarin related nephropathy: a case report and review of the literature.
Topics: Acetylcysteine; Acute Kidney Injury; Anticoagulants; Atrial Fibrillation; Female; Free Radical Scavengers; Heart Valve Prosthesis; Humans; Middle Aged; Warfarin; Withholding Treatment | 2016 |
Impact of antioxidant supplementations on cardio-renal protection in cardiac surgery: an updated and comprehensive meta-analysis and systematic review.
Topics: Acetylcysteine; Acute Kidney Injury; Antioxidants; Ascorbic Acid; Atrial Fibrillation; Cardiac Surgical Procedures; Dietary Supplements; Fatty Acids, Unsaturated; Humans; Incidence; Odds Ratio; Risk Factors; Treatment Outcome | 2016 |
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Blood Coagulation; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Flavonoids; Free Radical Scavengers; Heart; Humans; Hypertension; Patient Care Team; Phenols; Platelet Aggregation Inhibitors; Polyphenols; Stroke Volume; Venous Thromboembolism; Ventricular Dysfunction, Left | 2010 |
Practical prevention of cardiac remodeling and atrial fibrillation with full-spectrum antioxidant therapy and ancillary strategies.
Topics: Acetylcysteine; Antioxidants; Apoptosis; Atrial Fibrillation; Fibrosis; Heart Failure; Humans; Mitochondria; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxynitrous Acid; Superoxides | 2010 |
Pharmacologic prophylaxis of postoperative atrial fibrillation in patients undergoing cardiac surgery: beyond beta-blockers.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrillation; Calcium Channel Blockers; Cardiac Surgical Procedures; Digoxin; Fatty Acids, Omega-3; Hospital Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Postoperative Period; Sotalol | 2010 |
N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials.
Topics: Acetylcysteine; Aged; Aged, 80 and over; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Free Radical Scavengers; Humans; Male; Middle Aged; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic | 2012 |
8 trial(s) available for acetylcysteine and Auricular Fibrillation
| Article | Year |
|---|---|
Amiodarone with or without N-Acetylcysteine for the Prevention of Atrial Fibrillation after Thoracic Surgery: A Double-blind, Randomized Trial.
Topics: Acetylcysteine; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Humans; Inflammation; Postoperative Complications; Thoracic Surgery | 2022 |
Comparing the efficacy of N-acetylcysteine plus carvedilol versus carvedilol in the prevention of atrial fibrillation following coronary artery bypass graft surgery.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Atrial Fibrillation; Carvedilol; Coronary Artery Bypass; Humans; Postoperative Complications | 2022 |
The effect of intravenous N-acetylcysteine on prevention of atrial fibrillation after coronary artery bypass graft surgery: a double-blind, randomised, placebo-controlled trial.
Topics: Acetylcysteine; Administration, Intravenous; Adult; Aged; Atrial Fibrillation; Coronary Artery Bypass; Double-Blind Method; Electrocardiography; Female; Humans; Inflammation; Male; Middle Aged; Monitoring, Physiologic; Postoperative Complications; Receptors, Immunologic; Treatment Outcome | 2018 |
Prophylactic high-dose oral-N-acetylcysteine does not prevent atrial fibrillation after heart surgery: a prospective double blind placebo-controlled randomized clinical trial.
Topics: Acetylcysteine; Administration, Oral; Age Distribution; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiovascular Surgical Procedures; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebo Effect; Postoperative Complications; Premedication; Prevalence; Prospective Studies; Risk Factors; Sex Distribution; Survival Rate; Treatment Outcome | 2013 |
Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment.
Topics: Acetylcysteine; Aged; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Cardiac Surgical Procedures; Carvedilol; Double-Blind Method; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Inflammation; Leukocyte Count; Male; Metoprolol; Middle Aged; Oxidative Stress; Postoperative Period; Propanolamines; Prospective Studies; Treatment Outcome | 2014 |
N-acetyl cysteine for the conversion of atrial fibrillation into sinus rhythm after cardiac surgery: a prospective, randomized, double-blind, placebo-controlled pilot study.
Topics: Acetylcysteine; Aged; Atrial Fibrillation; Cardiac Surgical Procedures; Double-Blind Method; Female; Follow-Up Studies; Free Radical Scavengers; Heart Rate; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies | 2013 |
Metoprolol vs. carvedilol or carvedilol plus N-acetyl cysteine on post-operative atrial fibrillation: a randomized, double-blind, placebo-controlled study.
Topics: Acetylcysteine; Adult; Aged; Analysis of Variance; Anti-Arrhythmia Agents; Atrial Fibrillation; Carbazoles; Carvedilol; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Humans; Length of Stay; Metoprolol; Middle Aged; Postoperative Complications; Propanolamines; Treatment Outcome; Young Adult | 2013 |
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study.
Topics: Acetylcysteine; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Postoperative Complications | 2008 |
9 other study(ies) available for acetylcysteine and Auricular Fibrillation
| Article | Year |
|---|---|
N-Acetylcysteine and Postoperative Atrial Fibrillation: Comment.
Topics: Acetylcysteine; Atrial Fibrillation; Humans; Postoperative Complications; Postoperative Period; Risk Factors | 2023 |
N-Acetylcysteine and Postoperative Atrial Fibrillation: Reply.
Topics: Acetylcysteine; Atrial Fibrillation; Humans; Postoperative Complications; Postoperative Period; Risk Factors | 2023 |
N-Acetylcysteine and Postoperative Atrial Fibrillation: Comment.
Topics: Acetylcysteine; Atrial Fibrillation; Humans; Postoperative Complications; Postoperative Period; Risk Factors | 2023 |
[Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
Topics: Acetylcysteine; Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Atrial Fibrillation; Azithromycin; Cohort Studies; Comorbidity; Coronary Disease; COVID-19; COVID-19 Drug Treatment; Dabigatran; Disseminated Intravascular Coagulation; Female; Humans; Hypertension; Indoles; Interferon alpha-2; Intracranial Arteriosclerosis; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; SARS-CoV-2; Severity of Illness Index; Survival Analysis | 2021 |
N-acetylcysteine for the prevention of atrial fibrillation: beyond its antioxidant effect.
Topics: Acetylcysteine; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Surgical Procedures; Humans; Oxidative Stress; Postoperative Complications | 2008 |
Association between the use of non-antiarrhythmic drugs and postoperative atrial fibrillation.
Topics: Acetylcysteine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Cardiac Surgical Procedures; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged | 2010 |
Chronic heart failure and the substrate for atrial fibrillation.
Topics: Acetylcysteine; Action Potentials; Animals; Atrial Fibrillation; Atrial Function, Left; Calcium Channels, L-Type; Calcium Signaling; Cardiac Pacing, Artificial; Chronic Disease; Disease Models, Animal; Dogs; Female; Fibrosis; Heart Conduction System; Heart Failure; Male; Myocardial Contraction; Myocardium; Oxidation-Reduction; Oxidative Stress; Pilot Projects; Potassium Channels; Receptor, Angiotensin, Type 1; Refractory Period, Electrophysiological; Time Factors; Ventricular Function, Left | 2009 |
Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.
Topics: Acetylcysteine; Alleles; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Gene Deletion; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prospective Studies; Renin-Angiotensin System | 2007 |
N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study.
Topics: Acetylcysteine; Anti-Arrhythmia Agents; Atrial Fibrillation; Humans; Pilot Projects; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic | 2008 |